Which NC organizations would be impacted by Trump’s NIH funding cuts? Here’s a list
Editor’s note: This story was originally published on Tuesday, February 11. Some information may now be outdated.
A federal judge blocked the Trump’s administration’s attempt to cut hundreds of millions of dollars in medical research funding after 22 states sued to stop the change.
The National Institutes of Health announced Friday that it would limit indirect funding for research projects to 15%, The News & Observer reported, which could lead to nationwide layoffs.
Most NIH grants consist of both “direct” payments for conducting medical studies and “indirect” payments for administrative costs like building maintenance, shared lab staff and legal compliance.
The government and research institutions negotiate indirect rates, which historically added around 27% to award totals, though major institutions have often received 50% or more to support indirect expenses. (For example, UNC-Chapel Hill had negotiated an indirect cost rate of 55%.)
NIH funding cuts would mean universities would have to find ways to make cutbacks and could result in “massive layoffs” across the Triangle, UNC-Chapel Hill Chancellor Holden Thorp told The N&O.
Here’s how much NIH funding North Carolina gets and where it goes.
How much NIH funding does NC get?
North Carolina has received $17.7 billion in funding from the NIH since fiscal year 2015, and nearly three quarters of that money has gone to state universities and colleges, The N&O previously reported.
Duke and UNC-Chapel Hill are the largest beneficiaries of NIH funding in the state, receiving $5.6 billion and $4.9 billion, respectively, since 2015.
Which places in NC get NIH funding?
Though universities get a majority of North Carolina’s NIH funding, there are many places that get grants from the government.
Since 2024, Research Triangle Institute, which employs 6,000 staff in 90 countries, has received the third-most funding from the NIH of any North Carolina entity, getting nearly $397 million.
PPD Development LP, a pharmaceutical contract research organization based in Wilmington, and Rho Federal Systems Division, a pharmaceutical company based in Durham, have also received $56 million and $30 million, respectively, in federal funding from the NIH since 2024.
Here’s a list of North Carolina organizations that received NIH funding in 2024 and 2025:
21MedTech LLC
3-C Institute for Social Development
Adamas nanotechnologies, Inc.
Aegiscn, LLC
Affinergy, LLC
Aimmax Therapeutics, Inc.
Allucent Government Services (US) LLC
Altis Biosystems, Inc.
Amalgent Therapeutics, Inc.
Amissa, Inc.
Anelleo, Inc.
Appalachian State University
Ascent Bio-Nano Technologies, Inc.
Attagene, Inc.
Baebies, Inc.
Bedrock Therapeutics, Inc.
Bioaesthetics Corporation
Biokier, Inc.
Biomedinnovations, Inc.
Calla Health Foundation
Carolinas Medical Center
Cell Microsystems, Inc.
Civatech Oncology, Inc.
Collaborations Pharmaceuticals, Inc.
Couplet Care, LLC
Cytex Therapeutics Inc.
Davidson College
Deep Creek Pharma, LLC
Digital Health Navigation Solutions, LLC
Dignify Therapeutics, LLC
Dnali Data Technologies, Inc.
Duke University
East Carolina University
Eclipse Life Sciences, Inc.
Enfuego Therapeutics Inc.
Epicypher, Inc.
Equiti Foods, LLC
Eydis Bio, Inc.
Family Health International
Fayetteville State University
Focal Medical, Inc.
Foresightcares Inc.
Gateway Bio, Inc.
Geneventiv Therapeutics, Inc.
Glycan Therapeutics Corporation
Gradient Health Inc
Gramercy Research Group, LLC
Health Decisions Inc
Helixomer, Inc.
High Point University
Inhalon Biopharma, Inc.
Innovation Research And Training, Inc.
Insoma Bio, Inc.
Integrated Laboratory Systems, LLC
International Cannabinoid Res Society
International Mammalian Genome Society
Laderx LLC
Lamassu Bio Inc
Lamassu Pharma Inc.
Leading Edge Pharmtox, LLC
Lumbee Land Development, Inc.
Metabolon, Inc.
Mucommune, LLC
Nanodiagnostic Technology, LLC
NC State Department of Health & Human Services
Neurogt, Inc.
North Carolina Agri & Tech St Univ
North Carolina Central University
North Carolina State University Raleigh
Oncurie Inc.
One Cow Standing, LLC
Opus Genetics Inc.
Parion Sciences, Inc.
Phase, Inc.
Plakous Therapeutics, Inc.
PPD Development LP
Predictive, LLC
Prevention Strategies, LLC
Pulvinar Neuro LLC
Qatch Technologies, LLC
Quadridox, Inc.
Ramona Optics, Inc.
Reactive Biosciences Inc.
Redbud Labs, Inc.
Research Triangle Institute
Rho Federal Systems Division, Inc.
Sciome, LLC
Scion Neurostim, Llc
Scitovation, Llc
Sorbenta Inc
Southeast Clinical Oncol Res Consortium
T3D Therapeutics, Inc.
Theia Imaging LLC
Transchromix, LLC
Triangle Biotechnology, Inc.
Tripill Biotechnology, Corp.
University Of North Carolina At Chapel Hill
University Of North Carolina At Pembroke
University Of North Carolina Charlotte
University Of North Carolina Greensboro
University Of North Carolina Wilmington
Vindhya Data Science Inc.
Vortant Technologies, LLC
Wake Forest University
Wake Forest University Health Sciences
Winston-Salem State University
Xilis, Inc.
Adamas Nanotechnologies, Inc.
Baebies, Inc.
Data Driven Bioscience Inc
Duke University
East Carolina University
Family Health International
International Mammalian Genome Society
mHealth Systems, Inc
Mucommune, LLC
North Carolina Central University
North Carolina State University Raleigh
Ramona Optics, Inc.
Research Triangle Institute
University Of North Carolina At Chapel Hill
University Of North Carolina Charlotte
University Of North Carolina Greensboro
Vast Therapeutics, Inc.
Wake Forest University Health Sciences
Reporting by The News & Observer’s Brian Gordon and David Raynor contributed to this story.
This story was originally published February 11, 2025 at 5:02 PM.
